Cargando…

Obesity-Related Chronic Kidney Disease—The Role of Lipid Metabolism

Obesity is an independent risk factor for chronic kidney disease (CKD). The mechanisms linking obesity and CKD include systemic changes such as high blood pressure and hyperglycemia, and intrarenal effects relating to lipid accumulation. Normal lipid metabolism is integral to renal physiology and di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mount, Peter, Davies, Matthew, Choy, Suet-Wan, Cook, Natasha, Power, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693192/ https://www.ncbi.nlm.nih.gov/pubmed/26690487 http://dx.doi.org/10.3390/metabo5040720

Ejemplares similares

Pre-eclampsia is associated with altered expression of the renal sodium transporters NKCC2, NCC and ENaC in urinary extracellular vesicles
por: Hu, Chih-Chiang, et al.
Publicado: (2018)

The role of iron metabolism in chronic diseases related to obesity
por: Qiu, Fangyi, et al.
Publicado: (2022)

Optimal Obesity- and Lipid-Related Indices for Predicting Metabolic Syndrome in Chronic Kidney Disease Patients with and without Type 2 Diabetes Mellitus in China
por: Li, Hangtian, et al.
Publicado: (2022)

APOA2 Polymorphism in Relation to Obesity and Lipid Metabolism
por: Zaki, Moushira Erfan, et al.
Publicado: (2013)

The Outcome of Renal Ischemia-Reperfusion Injury Is Unchanged in AMPK-β1 Deficient Mice
por: Mount, Peter F., et al.
Publicado: (2012)

Editorial: Lipid metabolism in obesity
por: Giudetti, Anna Maria
Publicado: (2023)

ACE2 deficiency exacerbates obesity-related glomerulopathy through its role in regulating lipid metabolism
por: Chen, Yin-Yin, et al.
Publicado: (2022)

The Roles of Lipid Metabolism in the Pathogenesis of Chronic Diseases in the Elderly
por: Song, Rui, et al.
Publicado: (2023)

Weighing the evidence: obesity, metabolic syndrome, and the risk of chronic kidney disease
por: Gabbay, Ezra, et al.
Publicado: (2015)

Metabolically Healthy Obesity: Epidemiology, Criteria, and Implications in Chronic Kidney Disease
por: Cho, Yun Kyung, et al.
Publicado: (2022)

Novel Role of Gestational Hydralazine in Limiting Maternal and Dietary Obesity-Related Chronic Kidney Disease
por: Larkin, Benjamin P., et al.
Publicado: (2021)

The Role of Chloroplast Membrane Lipid Metabolism in Plant Environmental Responses
por: Cook, Ron, et al.
Publicado: (2021)

Chronic Kidney Disease, Obesity, and Hypertension: The Role of Leptin and Adiponectin
por: Tesauro, M., et al.
Publicado: (2012)

Role of microRNAs in Obesity-Related Kidney Disease
por: Caus, Maite, et al.
Publicado: (2021)

Correction: ACE2 deficiency exacerbates obesity-related glomerulopathy through its role in regulating lipid metabolism
por: Chen, Yin-Yin, et al.
Publicado: (2023)

No Role for Mast Cells in Obesity-Related Metabolic Dysregulation
por: Chmelař, Jindřich, et al.
Publicado: (2016)

Effects of roxadustat on anemia, iron metabolism, and lipid metabolism in patients with non-dialysis chronic kidney disease
por: Hirai, Keiji, et al.
Publicado: (2023)

Sex differences in obesity, lipid metabolism, and inflammation—A role for the sex chromosomes?
por: Zore, Temeka, et al.
Publicado: (2018)

Obesity and lipid-related parameters for predicting metabolic syndrome in Chinese elderly population
por: Gu, Zhan, et al.
Publicado: (2018)

Obesity- and lipid-related indices as a predictor of obesity metabolic syndrome in a national cohort study
por: Gui, Jiaofeng, et al.
Publicado: (2023)

Chronic Kidney Disease and Lipid Disorders
por: Zubovic, Sandra Vegar, et al.
Publicado: (2016)

Lipid Accumulation and Chronic Kidney Disease
por: Gai, Zhibo, et al.
Publicado: (2019)

Tryptophan metabolism, its relation to inflammation and stress markers and association with psychological and cognitive functioning: Tasmanian Chronic Kidney Disease pilot study
por: Karu, Naama, et al.
Publicado: (2016)

Predictive ability of obesity- and lipid-related indicators for metabolic syndrome in relatively healthy Chinese adults
por: Duan, Yuting, et al.
Publicado: (2022)

The role of oxidative stress in the development of obesity and obesity-related metabolic disorders
por: Čolak, Emina, et al.
Publicado: (2021)

Mutation of regulatory phosphorylation sites in PFKFB2 does not affect the anti-fibrotic effect of metformin in the kidney
por: Harley, Geoff, et al.
Publicado: (2023)

iTRAQ-based proteomic analysis of plasma reveals abnormalities in lipid metabolism proteins in chronic kidney disease-related atherosclerosis
por: Luczak, Magdalena, et al.
Publicado: (2016)

Obesity-related hypertension and chronic kidney disease: from evaluation to management
por: Jung, Mi-Hyang, et al.
Publicado: (2023)

The Role of the Gut Microbiome in Diabetes and Obesity-Related Kidney Disease
por: Zaky, Amgad, et al.
Publicado: (2021)

Metabolic syndrome, obesity and kidney stones
por: Hess, Bernhard
Publicado: (2012)

Metabolic acidosis and the progression of chronic kidney disease
por: Chen, Wei, et al.
Publicado: (2014)

Impact of bariatric surgery on glucose and lipid metabolism and liver and kidney function in food-induced obese diabetic rats
por: Long, Hong, et al.
Publicado: (2023)

Metabolomics insights into activated redox signaling and lipid metabolism dysfunction in chronic kidney disease progression
por: Chen, Hua, et al.
Publicado: (2016)

Effects of Elobixibat on Constipation and Lipid Metabolism in Patients With Moderate to End-Stage Chronic Kidney Disease
por: Matsuyama, Momoko, et al.
Publicado: (2022)

Effects of Body Weight Change on Development of Chronic Kidney Disease in Obese Metabolic Phenotypes
por: Toda, Akiko, et al.
Publicado: (2022)

The role of lipid metabolic reprogramming in tumor microenvironment
por: Yang, Kai, et al.
Publicado: (2023)

Metabolic Syndrome, Chronic Kidney, and Cardiovascular Diseases: Role of Adipokines
por: Tesauro, Manfredi, et al.
Publicado: (2011)

Increased expression and phosphorylation of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase isoforms in urinary exosomes in pre-eclampsia
por: Ellis, R., et al.
Publicado: (2019)

Lipid Disorders in NAFLD and Chronic Kidney Disease
por: Yang, Meng, et al.
Publicado: (2021)

Dietary Lipids and Dyslipidemia in Chronic Kidney Disease
por: Kochan, Zdzislaw, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lpn4rfihp7afakhcihb592svgh